Nkarta Frames Lupus Plans, Cost Cuts Into A Pleasing Picture For Investors

Stock Rises On NK Cell Updates, Move Into Autoimmune Diseases

 
• By Mandy Jackson
Blue growth graph business chart
Nkarta's stock doubled after its recent updates • Source: Shutterstock

More from Business

More from Scrip